Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile
Dr Jessamy Tiffen

@jesstiffen

Group Leader, Melanoma Epigenetics Laboratory, The Centenary Institute. Head of Centre for Cancer Innovations, The Centenary Institute

ID: 719994038

linkhttps://www.centenary.org.au/cen_author/dr-jessamy-tiffen/ calendar_today27-07-2012 11:36:49

394 Tweet

658 Followers

669 Following

Jamie Pei, PhD (@heyjamiepei) 's Twitter Profile Photo

It's a mistake to think that the only wins in the #PhD worth celebrating are the big flashy events - submission, acceptance, awards. Here are 30 other wins in the PhD you might think are "no big deal" 🧵 #phdlife #phdchat #academicchatter #academictwitter #phdtips

Centenary Institute (@centenaryinst) 's Twitter Profile Photo

The Dr Jessamy Tiffen lab is focused on understanding how epigenetic dysregulation drives melanoma development & how this differs between the sexes. More: centenary.org.au/research/labor… #worldcancerday #closethecaregap #centenaryinstitute #WorldCancerDay2024 #melanoma #Cancer #CancerResearch

The <a href="/JessTiffen/">Dr Jessamy Tiffen</a> lab is focused on understanding how epigenetic dysregulation drives melanoma development &amp; how this differs between the sexes. More: centenary.org.au/research/labor… #worldcancerday #closethecaregap #centenaryinstitute #WorldCancerDay2024 #melanoma #Cancer #CancerResearch
Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

FDA approves first tumour-infiltrating lymphocyte (TIL) therapy, bolstering hopes for cell therapies in solid cancers nature.com/articles/d4157…

Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

Estimating cancers attributable to physical inactivity in Australia - Journal of Science and Medicine in Sport jsams.org/article/S1440-…

Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

This is remarkable. Cancer in the complete absence of a single genetic mutation. Another win for team epigentics! nature.com/articles/s4158…

Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

More great work from my team on epigenetic BET inhibitors. Here we show they combine well with antiCTLA-4 immune checkpoint inhibition (ICI) to combat melanoma with innate resistance to antiPD-1/L1 (frontline) ICI in a mouse model. Cindy Hsin-Yi Tseng Abdullah Al Emran onlinelibrary.wiley.com/doi/10.1111/pc…

A/Prof Michelle McDonald (@michbal19) 's Twitter Profile Photo

I am looking for a post doc to join my new lab ⁦University of Sydney⁩! This is a great opportunity for an ECR to work with my team using cutting edge imaging approaches 🔬 to dive into bone metastatic breast cancer … and enjoy the Sydney life ☀️ 🏖️🤗 usyd.wd3.myworkdayjobs.com/en-US/USYD_EXT…

Centenary Institute (@centenaryinst) 's Twitter Profile Photo

You're invited to our FREE interactive online event Skin Deep: understanding melanoma. For more information and to register go to: centenary.org.au/event/skin-dee… #centenaryinstitute #melanoma #medicalresearch #medicalwebinar

You're invited to our FREE interactive online event Skin Deep: understanding melanoma. For more information and to register go to: centenary.org.au/event/skin-dee…
#centenaryinstitute #melanoma #medicalresearch #medicalwebinar
Samuel Hume (@drsamuelbhume) 's Twitter Profile Photo

The 10 biggest cancer papers of the last 10 years (in my opinion) 1. Blocking PD1 activates the immune response against cancer - especially if the cancer has more mutations nejm.org/doi/pdf/10.105…

The 10 biggest cancer papers of the last 10 years (in my opinion) 

1. Blocking PD1 activates the immune response against cancer - especially if the cancer has more mutations

nejm.org/doi/pdf/10.105…
Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

SEX! Now that I have your attention, check out our review on these fascinating yet under appreciated chromosomes with roles in cancer survival outcomes. onlinelibrary.wiley.com/doi/10.1111/pc…

Dr Jessamy Tiffen (@jesstiffen) 's Twitter Profile Photo

Super fun BBQ and swim at my house for past and present lab members and their families. Stephen and Alice are about to graduate with their MDs. Great science is so much more about the people than experiments. Cindy Hsin-Yi Tseng Centenary Institute

Super fun BBQ and swim at my house for past and present lab members and their families. Stephen and Alice are about to graduate with their MDs. Great science is so much more about the people than experiments. <a href="/DrHYTseng/">Cindy Hsin-Yi Tseng</a> <a href="/CentenaryInst/">Centenary Institute</a>
Simona Cristea (@simocristea) 's Twitter Profile Photo

Cancer statistics in 2025 🇺🇸- new report 🚨 Cancer is becoming a new disease. We're seeing a fundamental shift in who gets cancer, moving from a predominantly male, elderly disease to one that increasingly affects women and younger people. Key highlights 🧵

Cancer statistics in 2025 🇺🇸- new report 🚨

Cancer is becoming a new disease.

We're seeing a fundamental shift in who gets cancer, moving from a predominantly male, elderly disease to one that increasingly affects women and younger people.

Key highlights 🧵
Ziyad Al-Aly, MD (@zalaly) 's Twitter Profile Photo

1. What are the benefits and risks of GLP1? Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound). By Yan Xie, Taeyoung Choi and me 🧵 nature.com/articles/s4159…

Roychoudhuri Lab (@roychoudhurilab) 's Twitter Profile Photo

Thrilled to share new work led by Jie Yang in the lab published today in nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. Cambridge University CRUK Cambridge Centre rdcu.be/eci1U

Thrilled to share new work led by <a href="/JieYang437/">Jie Yang</a> in the lab published today in <a href="/Nature/">nature</a>. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. <a href="/Cambridge_Uni/">Cambridge University</a> <a href="/CRUKCamCentre/">CRUK Cambridge Centre</a>  rdcu.be/eci1U